<?xml version="1.0" encoding="UTF-8"?>
<ref id="B170-pharmaceutics-12-00688">
 <label>170.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Udayakumar</surname>
    <given-names>T.S.</given-names>
   </name>
   <name>
    <surname>Stoyanova</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Shareef</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Mu</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Philip</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Burnstein</surname>
    <given-names>K.L.</given-names>
   </name>
   <name>
    <surname>Pollack</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity</article-title>
  <source>Mol. Cancer Ther.</source>
  <year>2016</year>
  <volume>15</volume>
  <fpage>1353</fpage>
  <lpage>1363</lpage>
  <pub-id pub-id-type="doi">10.1158/1535-7163.MCT-15-0332</pub-id>
  <pub-id pub-id-type="pmid">26944919</pub-id>
 </element-citation>
</ref>
